TrialsgrambetaRCTs are beautiful

WISDOM

2014

Withdrawal of Inhaled Steroids During Optimised Bronchodilator Management

In 2,485 patients with severe COPD on triple therapy, stepwise withdrawal of inhaled corticosteroids was non-inferior for time to moderate-or-severe exacerbation compared with continued ICS.

Result

Efficacy: Time to first moderate or severe exacerbationHR 1.06 (95% CI 0.94-1.19)

Below 1 favours stepwise withdrawal of inhaled corticosteroids, above 1 favours continued ICS.

Also reported: FEV1 declined 38 mL more with withdrawal.

Original publication
Subtopic
ICS withdrawal
Design
Multicentre RCT
Relevance
Important: one of several pillars.
Source
Magnussen H, et al. N Engl J Med. 2014;371(14):1285-1294.doi 10.1056/NEJMoa1407154

Discussion & critique

ICS can be withdrawn in many COPD patients on dual bronchodilator therapy; risk concentrates in eosinophilia ≥300/µL.

Discussed in podcasts